Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines
Graphic
References (28)
- et al.
Trends in Pharm. Sci.
(1990) - et al.
Trends in Pharm. Sci.
(1991) - et al.
Ann. Rep. Med. Chem.
(1994) - et al.
Biomed. Chem. Lett.
(1993) - et al.
Biomed. Chem. Lett.
(1994) - et al.
J. Biol. Chem.
(1993) - et al.
Drugs of the Future
(1992) - et al.
- et al.
Drug News and Perspectives
(1993) - et al.
Clin. Exp. Allergy
(1992)
Mol. Pharmacol.
(1976)
J. Med. Chem.
(1989)
Drug Dev. Res.
(1990)
J. Med. Chem.
(1994)
Cited by (13)
Synthesis of 4-alkyl-pyrrolidine-3-carboxylic acid stereoisomers
2001, TetrahedronN-arylrolipram derivatives as potent and selective PDE4 inhibitors
1998, Bioorganic and Medicinal Chemistry LettersSynthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma
1998, Bioorganic and Medicinal Chemistry LettersQuaternary substituted PDE IV inhibitors II: The synthesis and in vitro evaluation of a novel series of γ-lactams
1998, Bioorganic and Medicinal Chemistry LettersQuaternary substituted PDE4 inhibitors I: The synthesis and in vitro evaluation of a novel series of oxindoles
1998, Bioorganic and Medicinal Chemistry Letters
Copyright © 1995 Published by Elsevier Ltd.